JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magovern, G. J.
Right arrow Articles by Burkholder, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magovern, G. J.
Right arrow Articles by Burkholder, J. A.

The Journal of Thoracic and Cardiovascular Surgery, Vol 73, 64-74, Copyright © 1977 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

A thirteen-year review of the Magovern-Cromie aortic valve

GJ Magovern, GA Liebler, WJ Cushing, SB Park and JA Burkholder

A review of 375 cases of aortic valve replacement with the Magovern- Cromie sutureless prosthesis demonstrated a 43 per cent survival rate 10 to 13 years following the operation. Of the 308 patients surviving zero to 30 days, 238 patients are alive after one to 14 years. A total of 70 patients (22 per cent died during the 14 year follow-up period. The actuarial survival rate of all patients at risk was 64 per cent at the fifth year and 51 per cent at the tenth year. For those patients who lived at least one year after surgery, the probability of survival was 84 per cent and 70 per cent at 5 and 10 years, respectively. These results compare favorably with reports of up to only 8 years with the Smeloff-Cutter and Starr-Edwards prostheses. There was only a 1.5 per cent incidence of perivalvular leak with this method of fixation, and no valve has migrated. Ball variance has not occurred with any valve inserted since 1964, and the incidence of thromboembolism with the Model A4 prosthesis is 2.4 per cent. Improvement in results depend on reduction of thromboembolism, lessening of late and operative morality rates, and by earlier operative intervention to reduce the late deaths from cardiogenic factors.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
G. J. Magovern, G. A. Liebler, S. B. Park, J. A. Burkholder, T. Sakert, and K. A. Simpson
Twenty-five-year review of the Magovern-Cromie sutureless aortic valve
Ann. Thorac. Surg., September 1, 1989; 48(3_suppl_1): S33 - S34.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. L. Grunkemeier, Q. Macmanus, D. R. Thomas, J. M. Luber, L. E. Lambert, Y.-F. Suen, and A. Starr
The Use of Time-Interrelated Covariates to Predict Survival Following Aortic Valve Replacement
Ann. Thorac. Surg., September 1, 1980; 30(3): 240 - 246.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1977 by The American Association for Thoracic Surgery.